key: cord-0868703-nsttd82n
authors: Crisafulli, Antonio; Pagliaro, Pasquale; Crisafulli, Antonio
title: Editorial: The COVID-19 Pandemic: A Challenge for the Cardiovascular Health
date: 2020-05-03
journal: Curr Cardiol Rev
DOI: 10.2174/1573403x1602200519115447
sha: e7fb36cd0998512032167d5018deb1f9e8968d1c
doc_id: 868703
cord_uid: nsttd82n

nan

The SARS-CoV-2 infection has the particularity of being correlated with the Renin Angiotensin System (RAS), which is pivotal in the regulation of saline homeostasis and blood pressure regulation [15] . The classical angiotensin converting enzyme (ACE), and the more recently discovered ACE2, are two important enzymes of the RAS. ACE converts angiotensin I (Ang I) to angiotensin II (Ang II), which is a potent vasoconstrictor, while ACE2 starting from various substrates, leads to the formation of angiotensin 1-7 (Ang 1-7), which exerts a potent vasodilator effect. Thus, ACE and ACE2 products act balancing each other to finely regulate vascular tone and blood pressure homeostasis. Ang II also induces sympathetic nervous activation, reactive oxygen species generation, and endothelial dysfunction. Moreover, it induces inflammation, thrombotic, proliferative, and fibrotic processes. Differently, Ang 1-7 mediates anti-inflammatory, anti-proliferative and anti-oxidative effects [15, 16] .

These different effects explain their opposite role in various pathological conditions, such as hypertension, diabetes, and cardiovascular diseases [15, 16] . SARS-CoV-2 uses ACE2 as a cellular receptor to invade target cells. In particular, the spike protein of SARS-CoV-2 virus is processed by transmembrane protease-serine 2 (TMPRSS2), favoring the binding of the spike protein to ACE2 [17] . ACE2 is importantly expressed and active in different tissues such as lungs, intestine, brain, testes, kidneys, and heart and their endothelium [18] . In particular, within the heart ACE2 is expressed by cardiomyocytes, macrophages, fibroblasts, endothelial cells, and pericytes [19] . Therefore, ACE2 plays a role in the mechanisms of acute myocardial and vascular injury caused by SARS-CoV-2.

Of note, sex hormones affect the homeostasis of RAS: both estrogens and androgens, which decrement with aging, have shown to up-regulate ACE2 expression; however, estrogen shifts the system towards the ACE2/Ang 1-7 formation [20, 21] . Although, the ACE/ACE2 activity ratio in the females is lower than that in the male serum, males may have higher expression of ACE2 in the lungs in comparison with females [22] .

Contentious results have been obtained in children and teenagers, in whom the expression and activity of ACE2 are unclear [23] . Some evidence suggests that the increased concentration of ACE2 receptors in lung pneumocytes in children may have a protective effect on severe clinical manifestations due to SARS-CoV-2 invasion. This supports a negative correlation between ACE2 expression and SARS-CoV-2 severe outcomes [24] . However, this result is in contrast with recent findings indicating that high expression of ACE2 increased the expression of genes involved in viral replication, and this may enhance the ability of the virus to enter the host cells [25] .

Of note, all the pathological conditions that are accompanied by an increase in ACE/ACE2 ratio are comorbidities that exacerbate the Covid-19 outcomes. These include hypertension, ischemic heart disease, and chronic renal failure [4, 26] . Therefore, it is likely that ACE2 down-regulation is a deleterious condition predisposing to Covid-19 exacerbation.

Of particular concern is the use of ACE inhibitors and AT1R Blockers (ARB). These drugs up-regulate the expression of ACE2 [27] , thereby theoretically enhancing the chance of virus binding. While it is well ascertained that ACE2 exerts beneficial effects on cardiovascular functions in patients with cardiovascular disease, it is still unknown whether high expression of ACE2 may transform into a sort of "Trojan horse" [28] . However, very recent findings reported that these drugs are not associ- ated with a poor outcome in hospitalized patients with COVID-19 [29] . Thus, the current recommendation for patients is not to discontinue these medications. Furthermore, it should be considered that the severity of COVID-19 is not related to viremia, but seems more related to the inflammation and cytokine storm.

From the therapeutic point of view, since the COVID-19 depletes ACE2, a potential therapy may be the administration of drugs that activate ACE2, which has anti-inflammatory effects. Potential candidates are diminazene aceturate, resorcinolnaphthalein, and xanthenone [30] . Also, recombinant ACE2 has been proposed in pneumonia [31] . It has also been suggested that a soluble ACE2 could quench the coronavirus by limiting its attachment to cellular ACE2 [32] .

Cardiovascular consequences of physical activity/inactivity and cardioprotection acquired through exercise are in our field of research and expertise. Therefore, we were particularly attracted by the possible consequences of physical inactivity due to this pandemic.

The notion that physical activity is protective for the cardiovascular apparatus is supported by a great deal of scientific evidence and has become a sort of cornerstone in the history of Medicine.

Regular physical activity has been associated with a significant reduction in total mortality and specifically in cardiac mortality rate [33, 34] . Conversely, an inactive lifestyle is an established risk [35] . To support the concept that regular exercise is a good practice to stay healthy, there is past evidence that physical capacity is a good predictor of increased risk of death from any cause in healthy subjects as well as in patients suffering from cardiovascular diseases [36, 37] .

Actually, regular physical activity reduces several risk factors, such as high blood pressure and cholesterol, and improves insulin sensitivity, vascular endothelium functions, and autonomic activity. Moreover, it induces beneficial structural adaptations in the coronary tree [38 -43] . Exercise probably confers cardioprotection against infarction, with cellular and molecular mechanisms which are still elusive and to be discovered [44 -46] .

In an attempt to hinder the spread of the COVID-19, the Chinese and the Italian governors have been the first to issue decrees that required all citizens to stay home unless they have valid reasons to go to work or markets for food or other documented valid reasons. It is a sort of "quarantine". More and more governments around the world have taken similar measures which have an innumerable series of consequences in everyone's life.

A direct consequence of these life restrictions is their impact on the possibility of being physically active. Several years ago, it was pointed out that cardiovascular diseases would have become the major cause of death in the world as a whole by the year 2020, this also considering sedentary lifestyle as a potential leading cause [47] . The COVID-19 outbreak will probably worsen this forecast because of the reduction in physical activity due to mandatory homestay. The current World Health Organization recommendations on physical activity for health promotion suggest that "Adults aged 18-64 should do at least 150 minutes of moderate-intensity aerobic physical activity throughout the week or do at least 75 minutes of vigorous-intensity aerobic physical activity throughout the week or an equivalent combination of moderate-and vigorous-intensity activity." (https://www.who.int/dietphysicalactivity/factsheet_adults/en/, accessed on April the 26 th 2020). It appears evident that it is very difficult to suit these recommendations for citizens in lockdown areas.

Thus, on one hand, the limitation of physical activities is required to counteract the COVID-19 outbreak, and on the other hand, this certainly entails problems related to the interruption or limitation of physical activities. Considering all the proof demonstrating the positive effects of physical activity on the general and cardiovascular health state, it is advisable that during the SARS-CoV-2 pandemic quarantine people keep exercising at home [48] . Good tools to be utilized are stationary bikes, treadmills, arm cranks, rowing machine and any other tool mimicking real outdoor exercise. The use of elastic band and weights allows to preserve muscle tropism, strength and tone. Also useful can be online-driven exercise sessions or the use of videos which avoids the loneliness of exercising alone. Even going up and down the stairs may be a good solution to keep the fitness level at its minimum.

Among other measures, there was the restriction of some outdoor activities, such as running. It is to be highlighted that, during the effort, hyperventilation increases the possibility to spread the virus more than the suggested social distancing of 1.5 m [49] , thus to limit outside exercise has a solid rationale. Moreover, in our opinion, the use of masks specifically adapted to high ventilation rates is advisable. In this regard, a study investigating the distance reached by droplets during hard efforts and how masks reduce this distance is warranted. To the best of our knowledge, none has investigated this topic.

An important consideration is related to the fact that regular physical activity affects RAS functioning. Exercise training can shift the balance of the RAS towards the protective arm ACE2/Ang1-7 [50] [51] [52] . Since the virus binds to ACE2, the potential over-expression of ACE2 in highly trained athletes may lead to assume that athletes have an increased chance of virus infection. Furthermore, once the body is infected, the SARS-CoV-2 has the capacity to deplete the ACE2. It is then possible that subjects with high expression of ACE2 may be particularly sensitive to RAS perturbation caused by the COVID-19. Although this may result counterintuitive, it is similar to the controversy regarding the ACE inhibitors or angiotensin receptor blockers. Although there are some indications that beneficial effects of ACE2 over-expression may prevail on the putative deleterious effects, these are just hypotheses that deserve attention and require further investigation.

Finally, it would be worth studying in the near future the impact of the "quarantine" on the classical cardiovascular risks factor which is counteracted by physical activity.

At the end of this editorial, we are left with few answers and many questions.

This pandemic is a real challenge for all the scientific community. We have to gather together as much scientific information as possible to fight this common enemy. So, it is essential to share information to rapidly find out solutions.

It will probably take months or years to win against the COVID-19.

We are only at the beginning of this battle.

Tonight (April 26 th , 2020), the Italian prime minister announced that from May 4th we will be allowed to do physical activities outside the home and in public parks keeping a minimum social distance of 2 meters, so we suggest jogging when the pandemic conditions are improving. We are confident that countless beneficial effects of exercise outweigh all other possible risks.

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)

The science underlying COVID-19: Implications for the cardiovascular system

for the China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China

Will children reveal their secret? The coronavirus dilemma

Suppression of COVID-19 outbreak in the municipality of

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status

Respiratory virus shedding in exhaled breath and efficacy of face masks

Asymptomatic Transmission, the Achilles' Heel of current strategies to control COVID-19

Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts

Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

on behalf of Prevention Treatment of VTE Associated with COVID-19 Infection Consensus Statement Group, Pulmonary Embolism Pulmonary Vascular Diseases Group of the Chinese Thoracic Society, Pulmonary Embolism Pulmonary Vascular Disease Working Committee of Chinese Association of Chest Physicians, National Cooperation Group on Prevention Treatment of Pulmonary Embolism Pulmonary Vascular Disease, National Program Office for Prevention Treatment of Pulmonary Embolism Deep Vein Thrombosis, China Grade Center

SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS

Rethinking the renin-angiotensin system and its role in cardiovascular regulation

Angiotensin-Converting Enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

The "his and hers" of the renin-angiotensin system

The role of androgens and estrogens on healthy aging and longevity

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov

Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China

Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation

Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19

High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation

Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism

Letter to the editor: Angiotensin-converting enzyme 2: an ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications

Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in Wuhan, China

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor

A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2

Thrombosis, physical activity, and acute coronary syndromes

Exercise as cardiovascular therapy

Effects of exercise and diet on chronic disease

Exercise capacity and mortality among men referred for exercise testing

Physical activity, all-cause mortality, and longevity of college alumni

Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: Effect of endurance exercise training

Effect of exercise training on endothelium-derived nitric oxide function in humans

The effect of exercise training on autonomic cardiovascular regulation: From cardiac patients to athletes

Wolfe Memorial lecture. Physical activity in prevention and treatment of coronary disease: The battle line is in exercise vascular cell biology

Mechanisms involved in cardioprotection induced by physical exercise

Consequences of Type 1 and 2 diabetes mellitus on the cardiovascular regulation during exercise: A brief review

Diabetic cardiomyopathy and ischemic heart disease: Prevention and therapy by exercise and conditioning

Cardioprotection acquired through exercise: The role of ischemic preconditioning

Association of exercise preconditioning with immediate cardioprotection: A review

Alternative protections of mortality and disability by cause 1990-2020: Global burden of disease study

Sanchis-Gomar F. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)

Turbulent gas clouds and respiratory pathogen emissions: Potential implications for reducing transmission of COVID-19

but not low, exercise volume shifts the balance of renin-angiotensin system toward ACE2/Mas receptor axis in skeletal muscle in obese rats

Modulation of the renin-angiotensin system in white adipose tissue and skeletal muscle: Focus on exercise training

Modulation of angiotensin II signaling following exercise training in heart failure